Skip directly to site content
Are You Still There?
Due to inactivity, you will be signed out in two minutes unless you click 'Continue'.

Are you still there?

Due to inactivity, you will be signed out in two minutes unless
you click 'Continue'.

Panel: 
AR Bank #

Biosample Accession #:

   


Panel:    |  Enterobacterales Carbapenem Breakpoint (BIT)  |  GN7F ARLN (Custom)  |  Piperacillin-tazobactam +aminoglycosides for Enterobacterales (PTA) (Custom)  |  PTA - BIT set only (Custom)


MIC (μg/ml) Results and Interpretation
Drug MIC (μg/ml) INT
S – I –R Interpretation (INT) derived from CLSI 2025 M100 S35
Device manufacturers and users of FDA cleared devices shall consult the FDA’s Antibacterial Susceptibility Test Interpretive Criteria       website for breakpoints recognized or recommended by FDA, and for information regarding FDA exceptions or additions to the applicable, recognized consensus standard.
Molecular Mechanisms of Resistance
CategoryGene
No data available
 
Disclaimer:
Propagation
MEDIUM
Medium: Label

GROWTH CONDITIONS
Temperature: Label°C
Atmosphere: Label

PROPAGATION PROCEDURE
Label
Storage Temperature & Biosafety
STORAGE TEMPERATURE: °C

BIOSAFETY LEVEL:


Disclaimer:
Isolate History
Date Action Performed
10/23/24INT was updated with a new value for Cefepime: from 'SDD' to 'R'
10/23/24MIC was updated with a new value for Cefepime: from '8' to '16'
01/19/24mCIM changed: from '---' to 'Negative'
04/20/23MIC was updated with a new value for Eravacycline: from '0.5' to '0.12'
04/10/23INT was updated with a new value for Tobramycin: from 'R' to 'I'
04/10/23INT was updated with a new value for Amikacin: from 'R' to 'I'
04/10/23INT was updated with a new value for Tobramycin: from 'S' to 'R'
04/10/23INT was updated with a new value for Amikacin: from 'S' to 'R'
Top of Page
TOP